Sleep and cognitive dysfunctions. Therapeutic approach
This review focuses on the possible mechanisms of sleep disorders in patients with cognitive impairment (CI) of different severity. The interrelation between CI, emotional disorders and insomnia, as well as the dependence of CI severity on the degree of sleep disorders, are discussed. The issues rel...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2014-05-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/379 |
id |
doaj-23b0b4cae23b42aab48ad1fe11a858ce |
---|---|
record_format |
Article |
spelling |
doaj-23b0b4cae23b42aab48ad1fe11a858ce2021-07-29T08:58:35ZrusIMA-PRESS LLCNevrologiâ, Nejropsihiatriâ, Psihosomatika2074-27112310-13422014-05-0161687310.14412/2074-2711-2014-1-68-73370Sleep and cognitive dysfunctions. Therapeutic approachM.G. Poluektov0I.S. Preobrazhenskaya1Department of Nervous Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, RussiaDepartment of Nervous Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, RussiaThis review focuses on the possible mechanisms of sleep disorders in patients with cognitive impairment (CI) of different severity. The interrelation between CI, emotional disorders and insomnia, as well as the dependence of CI severity on the degree of sleep disorders, are discussed. The issues related to treatment of sleep disorders in patients with CI, the advantages and disadvantages of modern somnogenic medications are studied. Recommendations on management of patients with a combination of sleep disorders and CI are provided. Data on the use of Egb 761 to treat CI no dementia and melatonin-based drugs to treat sleep disorders in patients with CI are presented.https://nnp.ima-press.net/nnp/article/view/379cognitive impairmentmild cognitive impairmentdementiaalzheimer's diseasevascular dementiavascular cognitive impair- mentsleep disordersegb 761melatonin-based drugs. |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
M.G. Poluektov I.S. Preobrazhenskaya |
spellingShingle |
M.G. Poluektov I.S. Preobrazhenskaya Sleep and cognitive dysfunctions. Therapeutic approach Nevrologiâ, Nejropsihiatriâ, Psihosomatika cognitive impairment mild cognitive impairment dementia alzheimer's disease vascular dementia vascular cognitive impair- ment sleep disorders egb 761 melatonin-based drugs. |
author_facet |
M.G. Poluektov I.S. Preobrazhenskaya |
author_sort |
M.G. Poluektov |
title |
Sleep and cognitive dysfunctions. Therapeutic approach |
title_short |
Sleep and cognitive dysfunctions. Therapeutic approach |
title_full |
Sleep and cognitive dysfunctions. Therapeutic approach |
title_fullStr |
Sleep and cognitive dysfunctions. Therapeutic approach |
title_full_unstemmed |
Sleep and cognitive dysfunctions. Therapeutic approach |
title_sort |
sleep and cognitive dysfunctions. therapeutic approach |
publisher |
IMA-PRESS LLC |
series |
Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
issn |
2074-2711 2310-1342 |
publishDate |
2014-05-01 |
description |
This review focuses on the possible mechanisms of sleep disorders in patients with cognitive impairment (CI) of different severity. The interrelation between CI, emotional disorders and insomnia, as well as the dependence of CI severity on the degree of sleep disorders, are discussed. The issues related to treatment of sleep disorders in patients with CI, the advantages and disadvantages of modern somnogenic medications are studied. Recommendations on management of patients with a combination of sleep disorders and CI are provided. Data on the use of Egb 761 to treat CI no dementia and melatonin-based drugs to treat sleep disorders in patients with CI are presented. |
topic |
cognitive impairment mild cognitive impairment dementia alzheimer's disease vascular dementia vascular cognitive impair- ment sleep disorders egb 761 melatonin-based drugs. |
url |
https://nnp.ima-press.net/nnp/article/view/379 |
work_keys_str_mv |
AT mgpoluektov sleepandcognitivedysfunctionstherapeuticapproach AT ispreobrazhenskaya sleepandcognitivedysfunctionstherapeuticapproach |
_version_ |
1721250678461956096 |